Skip to main content
Ralph A. Loren

Ralph A. Loren

Edwards Wildman Palmer LLP
Of Counsel
Search Me on: Edwards Wildman

Results for: Ralph A. Loren

    • Boston Tel +1 617 239 0233 | Fax +1 866 955 8976
    Ralph Loren, has practiced in all phases of intellectual property for over 35 years. His practice is primarily in litigation and deal work with an emphasis on licensing and due diligence. He has many years of patent prosecution experience, primarily in the life sciences and computer fields. He has litigated numerous patent infringement actions in diverse fields including biotechnology, chemical analyzers, computers, electronic equipment and mechanical devices. He has been involved in a number of interferences in the biotechnology and chemical/mechanical field. He has also litigated numerous trademark and copyright matters. His deal experience ranges from M&A and licensing in the pharma space to licensing and due diligence in the software field.

    Ralph lectures around the country on a variety of patent, licensing and litigation topics, including arbitration issues. He was a part-time professor at Boston University School of Law, where he taught patent law. He was also the author of a chapter entitled “Alternative Dispute Resolution” in the multi-volume Mathew Bender series, “Intellectual Property Counseling and Litigation.” He is listed as one of the leading Intellectual Property Attorneys in Massachusetts in Chambers USA and has been included in the Massachusetts Super Lawyers listing, a Thomson Reuters publication, numerous times. Ralph is also rated AV Preeminent by Martindale-Hubbell.

    Featured Experience

    • Edwards Wildman Team Leads Merger of Vision Insurance Companies

      In July 2013, an Edwards Wildman deal team led by Andrew Hughes and Paul Mahoney of our Providence office represented clients Nautic Partners, a private equity firm with more than $2.5 billion of capital under management, and Superior Vision, a Nautic Partners portfolio company based in California, in Superior Vision’s execution of a merger agreement providing for the acquisition of Block Vision, a Maryland-based national provider of vision insurance coverage. MORE

    • Edwards Wildman Team Leads Merger of Vision Insurance Companies

      In July 2013, an Edwards Wildman deal team led by Andrew Hughes and Paul Mahoney of our Providence office represented clients Nautic Partners, a private equity firm with more than $2.5 billion of capital under management, and Superior Vision, a Nautic Partners portfolio company based in California, in Superior Vision’s execution of a merger agreement providing for the acquisition of Block Vision, a Maryland-based national provider of vision insurance coverage. MORE

    • Represented Nautic Partners in its Acquisition of a Vision Insurance Company

      We represented Providence, RI-based Nautic Partners, a private equity firm, in a March 2012 leveraged acquisition of Superior Vision Holdings, Inc. MORE

    • Edwards Wildman Team Leads Merger of Vision Insurance Companies

      In July 2013, an Edwards Wildman deal team led by Andrew Hughes and Paul Mahoney of our Providence office represented clients Nautic Partners, a private equity firm with more than $2.5 billion of capital under management, and Superior Vision, a Nautic Partners portfolio company based in California, in Superior Vision’s execution of a merger agreement providing for the acquisition of Block Vision, a Maryland-based national provider of vision insurance coverage. MORE

    • Edwards Wildman Team Leads Merger of Vision Insurance Companies

      In July 2013, an Edwards Wildman deal team led by Andrew Hughes and Paul Mahoney of our Providence office represented clients Nautic Partners, a private equity firm with more than $2.5 billion of capital under management, and Superior Vision, a Nautic Partners portfolio company based in California, in Superior Vision’s execution of a merger agreement providing for the acquisition of Block Vision, a Maryland-based national provider of vision insurance coverage. MORE

    • Edwards Wildman Team Leads Merger of Vision Insurance Companies

      In July 2013, an Edwards Wildman deal team led by Andrew Hughes and Paul Mahoney of our Providence office represented clients Nautic Partners, a private equity firm with more than $2.5 billion of capital under management, and Superior Vision, a Nautic Partners portfolio company based in California, in Superior Vision’s execution of a merger agreement providing for the acquisition of Block Vision, a Maryland-based national provider of vision insurance coverage. MORE

    • Edwards Wildman Team Leads Merger of Vision Insurance Companies

      In July 2013, an Edwards Wildman deal team led by Andrew Hughes and Paul Mahoney of our Providence office represented clients Nautic Partners, a private equity firm with more than $2.5 billion of capital under management, and Superior Vision, a Nautic Partners portfolio company based in California, in Superior Vision’s execution of a merger agreement providing for the acquisition of Block Vision, a Maryland-based national provider of vision insurance coverage. MORE

    • Stemline Therapeutics, Inc IPO

      In January 2013, Edwards Wildman corporate, finance, insurance and intellectual property team members from Boston and Chicago advised Stemline Therapeutics, Inc. on its Initial Public Offering. MORE

    • Represented Nautic Partners in its Acquisition of a Vision Insurance Company

      We represented Providence, RI-based Nautic Partners, a private equity firm, in a March 2012 leveraged acquisition of Superior Vision Holdings, Inc. MORE

    • Edwards Wildman Team Leads Merger of Vision Insurance Companies

      In July 2013, an Edwards Wildman deal team led by Andrew Hughes and Paul Mahoney of our Providence office represented clients Nautic Partners, a private equity firm with more than $2.5 billion of capital under management, and Superior Vision, a Nautic Partners portfolio company based in California, in Superior Vision’s execution of a merger agreement providing for the acquisition of Block Vision, a Maryland-based national provider of vision insurance coverage. MORE

    • Edwards Wildman Team Leads Merger of Vision Insurance Companies

      In July 2013, an Edwards Wildman deal team led by Andrew Hughes and Paul Mahoney of our Providence office represented clients Nautic Partners, a private equity firm with more than $2.5 billion of capital under management, and Superior Vision, a Nautic Partners portfolio company based in California, in Superior Vision’s execution of a merger agreement providing for the acquisition of Block Vision, a Maryland-based national provider of vision insurance coverage. MORE

    • Edwards Wildman Team Leads Merger of Vision Insurance Companies

      In July 2013, an Edwards Wildman deal team led by Andrew Hughes and Paul Mahoney of our Providence office represented clients Nautic Partners, a private equity firm with more than $2.5 billion of capital under management, and Superior Vision, a Nautic Partners portfolio company based in California, in Superior Vision’s execution of a merger agreement providing for the acquisition of Block Vision, a Maryland-based national provider of vision insurance coverage. MORE

    • PTC Inc. Acquisition of Software Developer

      A large team of Edwards Wildman lawyers represented longtime client PTC in its acquisition of Enigma Information Systems Ltd., an Israeli software developer. MORE

    • Euroscreen S.A. license agreement

      Our Intellectual Property lawyers advised Euroscreen, S.A. in the license of technology and compounds to Ortho-McNeil-Janssen Pharmaceuticals,Inc.  Euroscreen is a private Belgian, preclinical-stage company that engages in drug discovery and development of small molecule drugs for unmet medical needs including inflammation, metabolism and sex hormone modulation. MORE

    • Stemline Therapeutics, Inc IPO

      In January 2013, Edwards Wildman corporate, finance, insurance and intellectual property team members from Boston and Chicago advised Stemline Therapeutics, Inc. on its Initial Public Offering. MORE

    • Euroscreen S.A. license agreement

      Our Intellectual Property lawyers advised Euroscreen, S.A. in the license of technology and compounds to Ortho-McNeil-Janssen Pharmaceuticals,Inc.  Euroscreen is a private Belgian, preclinical-stage company that engages in drug discovery and development of small molecule drugs for unmet medical needs including inflammation, metabolism and sex hormone modulation. MORE

    • Stemline Therapeutics, Inc IPO

      In January 2013, Edwards Wildman corporate, finance, insurance and intellectual property team members from Boston and Chicago advised Stemline Therapeutics, Inc. on its Initial Public Offering. MORE

    • Stemline Therapeutics, Inc IPO

      In January 2013, Edwards Wildman corporate, finance, insurance and intellectual property team members from Boston and Chicago advised Stemline Therapeutics, Inc. on its Initial Public Offering. MORE

    • Stemline Therapeutics, Inc IPO

      In January 2013, Edwards Wildman corporate, finance, insurance and intellectual property team members from Boston and Chicago advised Stemline Therapeutics, Inc. on its Initial Public Offering. MORE

    • Euroscreen S.A. license agreement

      Our Intellectual Property lawyers advised Euroscreen, S.A. in the license of technology and compounds to Ortho-McNeil-Janssen Pharmaceuticals,Inc.  Euroscreen is a private Belgian, preclinical-stage company that engages in drug discovery and development of small molecule drugs for unmet medical needs including inflammation, metabolism and sex hormone modulation. MORE

    • Euroscreen S.A. license agreement

      Our Intellectual Property lawyers advised Euroscreen, S.A. in the license of technology and compounds to Ortho-McNeil-Janssen Pharmaceuticals,Inc.  Euroscreen is a private Belgian, preclinical-stage company that engages in drug discovery and development of small molecule drugs for unmet medical needs including inflammation, metabolism and sex hormone modulation. MORE

    • Euroscreen S.A. license agreement

      Our Intellectual Property lawyers advised Euroscreen, S.A. in the license of technology and compounds to Ortho-McNeil-Janssen Pharmaceuticals,Inc.  Euroscreen is a private Belgian, preclinical-stage company that engages in drug discovery and development of small molecule drugs for unmet medical needs including inflammation, metabolism and sex hormone modulation. MORE

    Education +-

    Admissions+-

    Courts+-

    Memberships+-

    The hiring of a lawyer is an important decision that should not be based solely on advertisements. Prior results do not guarantee a similar outcome.